Cargando…

High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2(+) Inflammatory Breast Cancer

INTRODUCTION: Altered serum microRNA (miRNA) levels may be correlated with a dysregulated expression pattern in parental tumor tissue and reflect the clinical evolution of disease. The overexpression of miR-21, miR-10b, and miR-19a is associated with the acquisition of malignant characteristics (inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anfossi, Simone, Giordano, Antonio, Gao, Hui, Cohen, Evan N., Tin, Sanda, Wu, Qiong, Garza, Raul J., Debeb, Bisrat G., Alvarez, Ricardo H., Valero, Vicente, Hortobagyi, Gabriel N., Calin, George A., Ueno, Naoto T., Woodward, Wendy A., Reuben, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885405/ https://www.ncbi.nlm.nih.gov/pubmed/24416156 http://dx.doi.org/10.1371/journal.pone.0083113

Ejemplares similares

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells
por: Cohen, Evan N., et al.
Publicado: (2015)

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2016)

Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
por: Mego, M, et al.
Publicado: (2016)

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
por: Debeb, Bisrat G, et al.
Publicado: (2014)

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
por: Villodre, Emilly S., et al.
Publicado: (2020)

Inflammatory breast cancer appearance at presentation is associated with overall survival
por: Balema, Wintana, et al.
Publicado: (2021)

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models
por: Wolfe, Adam R., et al.
Publicado: (2016)

Circulating tumor cells in newly diagnosed inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2015)

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival
por: Stecklein, Shane R., et al.
Publicado: (2017)

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model
por: Lacerda, Lara, et al.
Publicado: (2015)

Inflammatory breast cancer: a model for investigating cluster-based dissemination
por: Jolly, Mohit Kumar, et al.
Publicado: (2017)

Influence of Macrophages on Vascular Invasion of Inflammatory Breast Cancer Emboli Measured Using an In Vitro Microfluidic Multi-Cellular Platform
por: Gadde, Manasa, et al.
Publicado: (2023)

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion
por: Villodre, Emilly S., et al.
Publicado: (2021)

Statin use in primary inflammatory breast cancer: a cohort study
por: Brewer, T M, et al.
Publicado: (2013)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

Inflammatory breast cancer: Clinical progress and the main problems that must be addressed
por: Giordano, Sharon H, et al.
Publicado: (2003)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
por: Kida, Kumiko, et al.
Publicado: (2020)

The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013)

Update on systemic treatment for newly diagnosed inflammatory breast cancer
por: Chainitikun, Sudpreeda, et al.
Publicado: (2020)

Prophylactic cranial irradiation reduces the incidence of brain metastasis in a mouse model of metastatic, HER2-positive breast cancer
por: Smith, Daniel L., et al.
Publicado: (2021)

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
por: Bertucci, François, et al.
Publicado: (2020)

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
por: Giuliano, Mario, et al.
Publicado: (2014)

Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer
por: Bambhroliya, Arvind, et al.
Publicado: (2018)

Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction
por: Raghav, K., et al.
Publicado: (2016)

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers
por: Li, Xiaotong, et al.
Publicado: (2021)

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10(th) Anniversary Conference
por: Woodward, Wendy A., et al.
Publicado: (2017)

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016)

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
por: Mego, Michal, et al.
Publicado: (2012)

Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro
por: Xu, Wei, et al.
Publicado: (2011)

High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells
por: Balema, Wintana, et al.
Publicado: (2023)

A target of potential RELAvance in inflammatory breast cancer
por: Eckhardt, Bedrich L., et al.
Publicado: (2017)

Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer
por: Debeb, Bisrat G., et al.
Publicado: (2015)

Bevacizumab in HER2-negative inflammatory breast cancer
por: Bertucci, François, et al.
Publicado: (2016)

Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2021)

Survivorship and Advocacy in Inflammatory Breast Cancer
por: Alexander, Angela, et al.
Publicado: (2018)

Targeting Signaling Pathways in Inflammatory Breast Cancer
por: Wang, Xiaoping, et al.
Publicado: (2020)

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients
por: Cheng, Y C, et al.
Publicado: (2010)

HER2/positive and HER2/low in inflammatory breast cancer recurrence
por: Movchan, Oleksii Volodimirovich, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_94q110qq4u74r8hhcag7bhpvhv